Novartis AG
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

Abstract:

Provided herein are compounds according to Formula (I) ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.5, and R.sup.7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.